Mariola Fotin-Mleczek, PhD


Chief Technology Officer

Mariola Fotin-Mleczek, PhD is our Chief Technology Officer (CTO).

She trained in biology at the University of Stuttgart. Her scientific expertise includes immunology, cell biology, signal transduction, apoptosis and mechanism of cellular uptake. She joined CureVac in May 2006 and was responsible for the development and preclinical testing of mRNA technology applied in different therapeutic areas: oncology, infection diseases and protein therapy. She is the inventor of multiple mRNA technology related key patents and she authored more than 30 scientific publications with a focus on mRNA technology.

Back to Executive Board